Nitric Oxide Synthase, antagonists & inhibitors
DBCAT001416Pharmacologic class
A DrugBank category of 15 drugs. 2 of them are approved.
What you can answer from here — as of August 24, 2016
Which targets do Nitric Oxide Synthase, antagonists & inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account